BioCardia Inc (BCDA) Q4 2025 Earnings Call Highlights: Promising Clinical Results Amid ... [Yahoo! Finance]
BioCardia, Inc. (BCDA)
US:NASDAQ Investor Relations:
biocardia.com/investors/press-releases/id/1037?pressreleaseid=41
Company Research
Source: Yahoo! Finance
Research and Development Expense: Increased by 13% to $5 million in 2025 from $4.4 million in 2024. Selling, General and Administrative Expenses: Decreased by 10% to $3.3 million in 2025 from $3.7 million in 2024. Net Loss: Increased to $8.2 million in 2025 from $7.9 million in 2024. Net Cash Used in Operations: Decreased to $7.5 million in 2025 from $7.9 million in 2024. Cash and Cash Equivalents: Ended the year at $2.5 million, slightly up from $2.4 million as of December 30th, 2024. Warning! GuruFocus has detected 3 Warning Signs with BCDA. Is BCDA fairly valued? Test your thesis with our free DCF calculator. Release Date: March 24, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points BioCardia Inc ( NASDAQ:BCDA ) has completed and presented final data from three clinical trials of their CardiAM therapy, showing promising results in treating ischemic heart failure. The CardiAM therapy has sho
Show less
Read more
Impact Snapshot
Event Time:
BCDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCDA alerts
High impacting BioCardia, Inc. news events
Weekly update
A roundup of the hottest topics
BCDA
News
- BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit [Seeking Alpha]Seeking Alpha
- BioCardia, Inc. (BCDA) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- BioCardia Reports 2025 Business Highlights and Financial ResultsGlobeNewswire
- BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026 [Yahoo! Finance]Yahoo! Finance
- BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026GlobeNewswire
BCDA
Sec Filings
- 3/26/26 - Form 4
- 3/24/26 - Form 8-K
- 3/24/26 - Form S-8
- BCDA's page on the SEC website